Pfizer Inc. Reports Shareholder Vote Results from Annual Meeting
Summary
Pfizer Inc. held its Annual Meeting of Shareholders on April 23, 2026, where shareholders voted on several key proposals. All nominees for election to the Board of Directors were elected. Shareholders also approved the Pfizer Inc. 2019 Stock Plan, as amended April 2026, and ratified KPMG LLP as the independent registered public accounting firm for the 2026 fiscal year. Additionally, the 2026 compensation of the Company's Named Executive Officers received advisory approval.
Why It Matters
These approvals at the Annual Meeting confirm shareholder support for Pfizer's current Board and its governance practices. The ratification of the auditor, approval of the stock plan, and advisory approval of executive compensation are routine but essential for the company's ongoing operations and strategic incentives.
These filing summaries are free and always will be. If this helped you spot material events, consider supporting us.
Want to see how PFE traded around this filing?
Check real-time charts and technical analysis on TradingView to see market reaction to this event.
View PFE Charts on TradingViewAffiliate link
Is this filing part of a pattern?
One disclosure is noise. Get a structured briefing covering 12 months of SEC filings, disclosure signals, and what to watch next.
Key Quote
“The nominees for election to the Company's Board of Directors set forth in Item 1 to the Company's Proxy Statement filed with the U.”
— From Item 5.07
Filing Details
Reported Items
Additional Information
- CIK Number
- 0000078003
- Filing Date
- Monday, April 27, 2026
- Filing Time
- 12:00 AM UTC
- Form Type
- 8-K
- Materiality Level
- low
- Sentiment
- positive